AT347427B - Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen-(1) und deren pharmazeutisch akzeptablen salzen - Google Patents

Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen-(1) und deren pharmazeutisch akzeptablen salzen

Info

Publication number
AT347427B
AT347427B AT682376A AT682376A AT347427B AT 347427 B AT347427 B AT 347427B AT 682376 A AT682376 A AT 682376A AT 682376 A AT682376 A AT 682376A AT 347427 B AT347427 B AT 347427B
Authority
AT
Austria
Prior art keywords
phenylaethanolen
amino
pharmaceutically acceptable
acceptable salts
producing new
Prior art date
Application number
AT682376A
Other languages
English (en)
Other versions
ATA682376A (de
Inventor
Leif Ake Svensson
Lars Magnus Soerenby
Kjell Ingvar Leopold Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of ATA682376A publication Critical patent/ATA682376A/de
Application granted granted Critical
Publication of AT347427B publication Critical patent/AT347427B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT682376A 1975-10-01 1976-09-15 Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen-(1) und deren pharmazeutisch akzeptablen salzen AT347427B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (2)

Publication Number Publication Date
ATA682376A ATA682376A (de) 1978-05-15
AT347427B true AT347427B (de) 1978-12-27

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT682376A AT347427B (de) 1975-10-01 1976-09-15 Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen-(1) und deren pharmazeutisch akzeptablen salzen

Country Status (19)

Country Link
JP (1) JPS5242840A (de)
AT (1) AT347427B (de)
AU (1) AU503212B2 (de)
BE (1) BE846837A (de)
CS (2) CS199644B2 (de)
DD (1) DD126278A5 (de)
DE (1) DE2640972A1 (de)
DK (1) DK141622B (de)
ES (1) ES451979A1 (de)
FI (1) FI762660A (de)
FR (1) FR2326183A1 (de)
GB (1) GB1542317A (de)
LU (1) LU75916A1 (de)
NL (1) NL7610845A (de)
NO (1) NO763345L (de)
NZ (1) NZ182165A (de)
SE (1) SE7510988L (de)
SU (2) SU638252A3 (de)
ZA (1) ZA765331B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7689T1 (de) 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
JP4920409B2 (ja) 2003-06-17 2012-04-18 アリーナ ファーマシューティカルズ, インコーポレイテッド 3−ベンズアゼピンを調製する方法
EP2471779A1 (de) 2006-04-03 2012-07-04 Arena Pharmaceuticals, Inc. Verfahren zur Trennung einer Mischung von (R)- und (S)-8-Chlor-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin
JP5404414B2 (ja) 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンおよびその中間体を調製するための方法
EP2288585A1 (de) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Verfahren zur herstellung von mit dem 5-ht2c-agonisten (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin verwandten zwischenprodukten
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
JP2013539470A (ja) 2010-09-01 2013-10-24 アリーナ ファーマシューティカルズ, インコーポレイテッド ロルカセリンと光学活性な酸との塩
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
WO2012030957A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
AU2011296015B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
UY34436A (es) 2012-10-09 2014-07-31 Arena Pharm Inc Metodo de control del peso

Also Published As

Publication number Publication date
NZ182165A (en) 1978-07-10
FI762660A (de) 1977-04-02
NO763345L (de) 1977-04-04
SE7510988L (sv) 1977-04-02
BE846837A (fr) 1977-04-01
ATA682376A (de) 1978-05-15
CS199643B2 (en) 1980-07-31
AU1812276A (en) 1978-04-06
DK141622B (da) 1980-05-12
LU75916A1 (de) 1978-05-16
JPS5242840A (en) 1977-04-04
DD126278A5 (de) 1977-07-06
SU638252A3 (ru) 1978-12-15
SU674669A3 (ru) 1979-07-15
CS199644B2 (en) 1980-07-31
ZA765331B (en) 1977-08-31
AU503212B2 (en) 1979-08-30
DK439776A (de) 1977-04-02
NL7610845A (nl) 1977-04-05
ES451979A1 (es) 1978-01-01
GB1542317A (en) 1979-03-14
FR2326183A1 (fr) 1977-04-29
DE2640972A1 (de) 1977-04-14

Similar Documents

Publication Publication Date Title
ATA800876A (de) Verfahren zur herstellung von neuen 2-phenyl-3- aroylbenzothiophenen und 2-phenyl-3- -aroylbenzothiophen-1-oxiden und von deren salzen
AT340895B (de) Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
AT375366B (de) Verfahren zur herstellung von neuen indolderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
AT347427B (de) Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen-(1) und deren pharmazeutisch akzeptablen salzen
AT365166B (de) Verfahren zur herstellung von neuen peptidderivaten und deren salzen
AT347952B (de) Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren salzen
AT353970B (de) Verfahren zur herstellung von neuen 7-methoxy- cephalosporinen und deren salzen
AT350552B (de) Verfahren zur herstellung von neuen propargyl- 2-phenylamino-imidazolinen-(2) und deren saeureadditionssalzen
AT348993B (de) Verfahren zur herstellung von neuen aminoacetophenon-derivaten und von deren salzen
AT346303B (de) Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen
AT356304B (de) Verfahren zur herstellung von neuen n2- arylsulfonyl-l-argininamiden und deren salzen
AT353960B (de) Verfahren zur herstellung von neuen bis-peni- cillanoyloxy-alkanen und deren pharmazeutisch annehmbaren salzen
ATA328376A (de) Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo(2,2,2)octanen und deren saureadditionssalzen
AT340896B (de) Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT352724B (de) Verfahren zur herstellung von neuen substi- tuierten sulfoximiden und deren salzen
AT342565B (de) Verfahren zur herstellung von neuen 3,4-dichlorphenon-o-(2-aminoathyl)-oximathern und deren saureadditionssalzen
AT358588B (de) Verfahren zur herstellung von neuen 1,2,3,4- -tetrahydroisochinolinen und deren salzen
AT340897B (de) Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT366057B (de) Verfahren zur herstellung von neuen peptidderivaten und deren salzen
AT352727B (de) Verfahren zur herstellung von neuen indol- derivaten und deren salzen
AT342021B (de) Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT340894B (de) Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen
AT356293B (de) Verfahren zur herstellung von neuen d-6-alkyl-8 -zyanmethylergolinen-i und deren salzen
AT367750B (de) Verfahren zur herstellung von neuen n2-arylsulfonyl-l-argininamiden und deren salzen
ATA392379A (de) Verfahren zur herstellung von neuen benzo(c)-chinolinen und deren pharmazeutisch vertraeglichen saeureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee